240 likes | 252 Views
The Second Stop TB Partners’ Forum Keynote address: Marcos Espinal Executive Secretary. 24 March 2004 – New Delhi, India. Overview. Progress: Fulfilling Amsterdam and Washington Preview: Plotting the way forward Partners: Everyone is necessary. Review progress through 2003.
E N D
The Second Stop TB Partners’ ForumKeynote address: Marcos EspinalExecutive Secretary 24 March 2004 – New Delhi, India
Overview • Progress: Fulfilling Amsterdam and Washington • Preview: Plotting the way forward • Partners: Everyone is necessary 24 March 2004
Review progress through 2003 “The Global Stop TB Partnership is working” • Grown 50 fold: 280 members • Accelerated TB control progress and funding • Become a model for international public health partnerships • Reach out to new partners—e.g. the private sector and civil society 24 March 2004
Achievements & Aims 2001–2005 “Global Firsts” The Global Plan to Stop TB, the Global DOTS Expansion Plan, the Global Drug Facility (GDF), the Green Light Committee (GLC) and the link with the Global Fund to Fight AIDS, TB and Malaria (GFATM) • By 2001: National plans and increased commitments • By 2002: NIACCs, accelerating detection rates to 37%, and a fully operational GDF • By 2005: 70/85 TB control targets 24 March 2004
The Global Plan to Stop TB • Working Group on DOTS Expansion • 180 countries implementing DOTS • Working Group on TB/HIV • Policy for TB/HIV collaborative activies • Working Group on DOTS-Plus for MDR-TB • Treatment for MDR-TB in more than 10 countries • Working Group on New Diagnostics • Enabling environment for commercial tool development • Working Group on New TB Drugs • Pipeline of promising compounds • Working Group on New Vaccines • Two vaccine candidates entering phase I clinical trials 24 March 2004
DOTS coverage non-DOTS < 10% pop 10 - 90% pop > 90% pop low incidence, non-DOTS No report Progress DOTS in 180 countries 24 March 2004
It can be done—Achieved and sustained in 6 countries for four years! 100 Malta Maldives TARGET ZONE Cambodia Viet Nam Tonga Cuba Solomon Is Peru Fiji Tunisia Morocco Bosnia & Hezegovina Treatment success (%) Hong Kong Samoa Qatar 85 Oman Uruguay Mongolia Marshall Is Nicaragua Chile Kyrgyzstan Morocco St Lucia Kazakhstan 80 Venezuela Guatemala Djibouti Kenya El Salvador Slovenia Sri Lanka French Polynesia Tanzania South Africa Turks & Caicos Is Portugal Italy Lebanon USA Latvia 70 DR Congo 50 60 70 80 90 100 110 120 DOTS detection rate (%) 24 March 2004
It can be donein your country 100 TARGET ZONE 85 % 90 Treatment success (%) 80 70 50 60 70 80 90 100 110 120 70 % DOTS detection rate (%) 24 March 2004
Global Drug Facility(GDF) Creating a “model,” since 2001 it has: • Supplied TB drugs to 1.7 million DOTS patients • Committed drugs – 2.8 million patients in 58 countries • Raised and committed US$ 30 million in grants • Increased delivery-efficiency, slashed drug prices • Advanced combination treatments • Established direct procurement service and White List of suppliers • Signed an agreement with Novartis through WHO to provide free TB drugs for 500 000 patients over the next 5 years 24 March 2004
The Partnership’s “Report Card” First independent external evaluation: • Scored “extremely high” marks • Added value, new initiatives, increased funding • Made progress against TB • Supported new diagnostics, drugs and vaccines • Operationalized GDF and GLC • Increased political commitment to the Global Plan We‘ve made a great start but ... 24 March 2004
The clock is ticking …This is no time for complacency II. The WayForward 24 March 2004
II. Preview of the future Plotting the way forward 2005 (Global Targets: 70/85) 2015 (Millennium Development Goals: halving prevalence and mortality) 24 March 2004
Accelerate progress 2005 Win the “case race” ONE MILLION TB PATIENTS EXTRA EVERY YEAR 24 March 2004
Accelerate progress 2005 Win the “case race” • Double DOTS detection from 37% to 70% by: • ensuring diagnosis and cure of known TB cases according to DOTS standards • recruiting patients from non-DOTS participating clinics and hospitals and from beyond the public health systems; • Inch up treatment cure rates from 82% to 85% • Strengthen focus on countries and communities • Focus on TB’s human face 24 March 2004
Intensify action 2005 Bold initiatives: • ISAC: Emergency ‘Intensified Support & Action Countries’ acceleratesefforts in lagging HBCs • PPM DOTS: The public-private and public-public Mix DOTS casts the health care net wider • Global Plan Phase I: Finalize and secure funding 24 March 2004
Fill the resource gapin the Global Plan Funding and gaps for partnership activities, 2001–2005 10 US$ billions Total gap: US$ 3.8 billion 41% of global plan cost 8 6 4 Gap Current-External 2 Current-National 0 DOTS Expansion Adapting DOTS R & D Partnership Total 24 March 2004
Why long-term goals matter • TB will not go away tomorrow • TB is still a disease of the poor • Ill health and poverty are a vicious circle • Effective interventions exist; need to reach more people • Improve national TB control policies, institutions, investment • Coordinate partner-donor efforts The LIVES and CASES prevented are the bottom line 24 March 2004
Long-term goals2015 2nd Ad Hoc Committee recommendations : • Consolidate, sustain, advance achievements to date • Enhance political commitment • Address the health workforce crisis • Strengthen health systems, especially PHC delivery • Accelerate responses to the TB-HIV/AIDS emergency • Mobilize communities and the private sector • Invest in R&D to shape the future 24 March 2004
Long-term goals2015 Global Plan To Stop TB II Poverty Reduction Strategy Papers Investments plans based on well-documented needs and costing scenarios 24 March 2004
Energize partnerships Partnerships play a strong role: • Countries: Strengthen / building partnerships • HIV/AIDS community: Make TB a major issue • Diverse partners: Define complementary roles • Donors: Cultivate investments, expand the base • Media: Raise awareness, increase advocacy & networks • Stakeholders: Broaden the range 24 March 2004
Develop new tools To defeat the mutable TB microbe, we must upscale efforts to develop: • New diagnostics: FIND, TDR, • New TB drugs: Global Alliance, Novartis Institute, Glaxo Welcome • New vaccines: Aeras 24 March 2004
III. Partners: To evolve dynamically and fulfil • the Amsterdam Declaration and • the Washington Commitment All of us here today must keep the New Delhi Pledges 24 March 2004
Let us not fail “We don’t need more promises; we need to deliver on those already made.” - MDGs High-Level Forum, January 2004 24 March 2004
Keep the pledges The reward will be found most meaningfully in the faces of those whose lives have been saved and health restored through our unremitting efforts. 24 March 2004